Q1 2014 13F Holders as of 3/31/2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
114M
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
9.56M
-
Shares change
-
+3.15M
-
Total reported value, excl. options
-
$92.8M
-
Value change
-
+$30.7M
-
Number of buys
-
10
-
Number of sells
-
-8
-
Price
-
$9.74
Significant Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q1 2014
23 filings reported holding FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share as of Q1 2014.
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.56M shares
of 114M outstanding shares and own 8.36% of the company stock.
Largest 10 shareholders include FMR LLC (3.05M shares), Polaris Venture Management Co. V, L.L.C. (2.47M shares), WELLINGTON MANAGEMENT CO LLP (1.12M shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (1.11M shares), ORBIMED ADVISORS LLC (693K shares), Board of Trustees of The Leland Stanford Junior University (304K shares), FARALLON CAPITAL MANAGEMENT LLC (275K shares), PRINCIPAL FINANCIAL GROUP INC (204K shares), VANGUARD GROUP INC (149K shares), and Bank of New York Mellon Corp (38.4K shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.